Development of new immunotherapeutic strategies relies on the ability to activate the right cells at the right place and at the right moment and on the capacity of these cells to home to the right organ(s). Skin delivery has shown high potency for immunotherapeutic administration. However, an adequate in vivo model of human skin immunity is still a critical bottleneck. We demonstrated here that the skin of human immune system mice is colonized by human hematopoietic cells, mainly human T cells and that complementation with human antigen-presenting cells at the vaccination site allowed the induction of an immune response.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/exd.13340 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!